Qualitative Analysis of Tumor-Infiltrating Lymphocytes across Human Tumor Types Reveals a Higher Proportion of Bystander CD8+ T Cells in Non-Melanoma Cancers Compared to Melanoma
Authors:
- Aishwarya GokuldassAGAishwarya Gokuldass
- Arianna DraghiADArianna Draghi
- Krisztian PappKPKrisztian Papp
- Troels Holz BorchTBTroels Holz Borch
- Morten NielsenMNMorten Nielsen
- Marie Christine Wulff WestergaardMWMarie Christine Wulff Westergaard
- Rikke AndersenRARikke Andersen
- Aimilia SchinaASAimilia Schina
- Kalijn Fredrike BolKBKalijn Fredrike Bol
- Christopher Aled ChamberlainCCChristopher Aled Chamberlain
- Mario PrestiMPMario Presti
- Özcan MetÖMÖzcan Met
Open Access
Abstract
Background: Human intratumoral T cell infiltrates can be defined by quantitative or qualitative features, such as their ability to recognize autologous tumor antigens. In this study, we reproduced the tumor-T cell interactions of individual patients to determine and compared the qualitative characteristics of intratumoral T cell infiltrates across multiple tumor types. Methods: We employed 187 pairs of unselected tumor-infiltrating lymphocytes (TILs) and autologous tumor cells from patients with melanoma, renal-, ovarian-cancer or sarcoma, and single-cell RNA sequencing data from a pooled cohort of 93 patients with melanoma or epithelial cancers. Measures of TIL quality including the proportion of tumor-reactive CD8+ and CD4+ TILs, and TIL response polyfunctionality were determined. Results: Tumor-specific CD8+ and CD4+ TIL responses were detected in over half of the patients in vitro, and greater CD8+ TIL responses were observed in melanoma, regardless of previous anti-PD-1 treatment, compared to renal cancer, ovarian cancer and sarcoma. The proportion of tumor-reactive CD4+ TILs was on average lower and the differences less pronounced across tumor types. Overall, the proportion of tumor-reactive TILs in vitro was remarkably low, implying a high fraction of TILs to be bystanders, and highly variable within the same tumor type. In situ analyses, based on eight single-cell RNA-sequencing datasets encompassing melanoma and five epithelial cancers types, corroborated the results obtained in vitro. Strikingly, no strong correlation between the proportion of CD8+ and CD4+ tumor-reactive TILs was detected, suggesting the accumulation of these responses in the tumor microenvironment to follow non-overlapping biological pathways. Additionally, no strong correlation between TIL responses and tumor mutational burden (TMB) in melanoma was observed, indicating that TMB was not a major driving force of response. No substantial differences in polyfunctionality across tumor types were observed. Conclusions: These analyses shed light on the functional features defining the quality of TIL infiltrates in cancer. A significant proportion of TILs across tumor types, especially non-melanoma, are bystander T cells. These results highlight the need to develop strategies focused on the tumor-reactive TIL subpopulation.Keywords
Funding Information
- Kræftens Bekæmpelse (R148-A9862, R204-A12535)
- Region Hovedstaden (R146-A5693)
- Lundbeck Foundation (R233-2016-3728)
- Danmarks Frie Forskningsfond (8045-00067B)
- Dansk Kræftforsknings Fond (FID2038024)
- Nemzeti Kutatási, Fejlesztési és Innovaciós Alap (FIEK_16-1-2016-0005)
This publication has 56 references indexed in Scilit:
- CD137 Accurately Identifies and Enriches for Naturally Occurring Tumor-Reactive T Cells in TumorClinical Cancer Research, 2014
- Signatures of mutational processes in human cancerNature, 2013
- Methods to Improve Adoptive T-Cell Therapy for Melanoma: IFN-γ Enhances Anticancer Responses of Cell Products for InfusionJournal of Investigative Dermatology, 2013
- Adoptive cell therapy with autologous tumor infiltrating lymphocytes and low-dose Interleukin-2 in metastatic melanoma patientsJournal of Translational Medicine, 2012
- Dissection of T-cell Antigen Specificity in Human MelanomaCancer Research, 2012
- Characterization and Comparison of ‘Standard’ and ‘Young’ Tumour‐Infiltrating Lymphocytes for Adoptive Cell Therapy at a Danish Translational Research InstitutionScandinavian Journal of Immunology, 2011
- Bimodal ex vivo expansion of T cells from patients with head and neck squamous cell carcinoma: a prerequisite for adoptive cell transferCytotherapy, 2011
- The cytologic criteria of malignancyJournal of Cellular Biochemistry, 2010
- FOXP3 expression accurately defines the population of intratumoral regulatory T cells that selectively accumulate in metastatic melanoma lesionsBlood, 2008
- Ex vivo identification, isolation and analysis of tumor-cytolytic T cellsNature Medicine, 2003